Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT05416996

A Study of Telemedicine Shared Medical Appointments (SMAs) Versus Individual Telemedicine Visits for People With Prostate Cancer

The purpose of this study is to see if a telemedicine group doctor's appointment is a practical (feasible) and acceptable method for following people with prostate cancer being managed with active surveillance when compared with the usual approach of individual telemedicine visits, which involve the participant visiting a doctor on their own. The researchers will compare the telemedicine group and individual visits by measuring on participant satisfaction and quality of life in each type of visit. Telemedicine is the use of secure video technology on a desktop computer, laptop, smartphone, or tablet to provide and receive healthcare from a distance.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Notify Me

Key information

Conditions

Prostate Cancer Genital Diseases Genital Diseases, Male Genital Neoplasms, Male Male Urogenital Diseases Neoplasms Neoplasms by Site Prostatic Diseases Prostatic Neoplasms Urogenital Diseases Urogenital Neoplasms

Age range

18 year and older

Sex eligibility

Male

Study type

Observational

Primary location

Memorial Sloan Kettering Cancer Center

New York, 10065, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • A scheduled appointment for a subsequent Active Surveillance (AS) follow-up visit for management of localized prostate cancer
  • Biopsy Gleason score 3+3=6 (Grade Group 1) or biopsy Gleason score 3+4=7 (Grade Group 2)
  • Clinical T stage ≤T2B
  • Access to a device with Zoom
  • Ability to speak and understand English

Exclusion criteria

  • Plan to undergo a prostate biopsy at this follow-up visit

Treatment and study plan

Primary outcomes

  1. accrual number

    Time frame: 1 year

  2. patient satisfaction

    Time frame: 1 week

    using MSK Engage portal survey

Secondary outcomes

  1. adherence to active surveillance

    Time frame: 6 months

    the number who drop out of AS in the absence of disease progression

Other outcomes

  1. Functional status

    Time frame: 1 year

    These patient-reported outcomes are captured electronically and using validated questionnaires as part of the standard of care at MSK via MSK Engage. (anxiety, quality of life, urinary function, and erectile function)

Sponsors and collaborators

Lead sponsor

Memorial Sloan Kettering Cancer Center

Other

Registry information

Official study title

Feasibility Study of Randomizing Patients to Telemedicine Shared Medical Appointments Versus Telemedicine Single Visits for Men With Prostate Cancer on Active Surveillance

Important dates

Study start
2022
Primary completion
2027
Study completion
2027
First posted
Jun 14, 2022
Registry last updated
Jul 21, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.